Fo-Ti (Polygonum multiflorum)

Fo-ti (Polygonum multiflorum) contains bioactive compounds including tetrahydroxystilbene glucoside (TSG) and emodin that demonstrate anti-inflammatory and neuroprotective properties. TSG modulates PPAR-gamma signaling while emodin inhibits acetylcholinesterase enzyme activity.

Origin & History

Fo-Ti is the root of Polygonum multiflorum (also known as Pleuropterus multiflorus), a climbing plant native to central and southern China, Taiwan, Vietnam, and other East Asian regions. The herb is available in multiple forms including crude (raw) herb, processed preparations, and various extracts (water, ethanol, acetone), with processing significantly altering the chemical profile and reducing toxicity compared to the raw herb.

Historical & Cultural Context

Fo-Ti has been used in traditional Chinese medicine for centuries for anti-aging effects, immune support, and general health promotion. The herb traditionally exhibits a wide spectrum of anecdotal pharmacological effects including anti-aging, immunologic, neuroprotective, anticancer, and anti-inflammatory properties.

Health Benefits

• Anti-inflammatory effects: TSG and emodin compounds decrease inflammation by increasing PPAR-gamma and decreasing NF-kB signaling (evidence from in vitro studies only)
• Cognitive support: Emodin inhibits acetylcholinesterase and may reduce amyloid plaque formation (evidence from test tube studies only)
• Cardiovascular protection: TSG prevented atherosclerosis by reducing blood lipids and suppressing inflammation in animal models (no human clinical evidence)
• Immune stimulation: Sugars and anthraquinone glycosides stimulate T cells, B cells, and natural killer cells (in vitro evidence only)
• Lipid reduction: One small human trial (n=42) using an herbal mixture containing Fo-Ti showed reduced LDL cholesterol and triglycerides, though other ingredients likely contributed

How It Works

TSG (tetrahydroxystilbene glucoside) activates PPAR-gamma receptors while suppressing NF-kB inflammatory signaling pathways. Emodin inhibits acetylcholinesterase enzyme activity and may interfere with amyloid-beta plaque formation through antioxidant mechanisms. These compounds work synergistically to reduce oxidative stress and neuroinflammation at the cellular level.

Scientific Research

Clinical evidence for Fo-Ti in humans is severely limited, with only one small trial of 42 participants using an herbal mixture containing Fo-Ti showing reduced LDL cholesterol and triglycerides. The vast majority of available evidence comes from in vitro (test tube) and animal studies rather than randomized controlled trials in humans. No PubMed PMIDs are provided in the available research for human clinical trials.

Clinical Summary

Current research on fo-ti is limited to in vitro and animal studies, with no robust human clinical trials available. Laboratory studies show TSG reduces inflammatory markers by 40-60% in cell cultures at concentrations of 10-50 μM. Emodin demonstrates acetylcholinesterase inhibition with IC50 values around 25 μg/mL in test tube studies. Human clinical evidence is needed to confirm therapeutic effects and optimal dosing protocols.

Nutritional Profile

Fo-Ti (Polygonum multiflorum) is not consumed for macronutrient value but rather for its bioactive phytochemical profile. Key compounds include: • **Stilbenes**: 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside (TSG) is the principal bioactive, typically standardized at 1.0–5.0% in dried root preparations and up to 10–15% in concentrated extracts; possesses antioxidant and anti-inflammatory activity. • **Anthraquinones**: Emodin (0.1–1.5% in raw root, higher in processed forms), chrysophanol, rhein, and physcion; these contribute to laxative effects and enzyme-inhibitory bioactivities. Processing (steaming with black bean juice, 'Zhi He Shou Wu') significantly alters the emodin-to-TSG ratio, reducing free anthraquinone content and increasing combined/bound anthraquinone glycosides. • **Tannins**: Condensed tannins including catechin and epicatechin derivatives (approximately 1–5% of dry weight); contribute to astringent and antioxidant properties but may reduce bioavailability of co-consumed minerals. • **Phospholipids**: Lecithin present in modest amounts (~1.2–2.0%), historically credited with some of the herb's cholesterol-modulating claims. • **Polysaccharides**: Crude polysaccharides approximately 4–8% of dry weight; may contribute to immunomodulatory effects. • **Minerals**: Contains trace amounts of iron, zinc, manganese, and selenium, though concentrations vary widely with soil and growing conditions (iron ~50–200 mg/kg dry weight; zinc ~15–60 mg/kg). • **Vitamins**: No significant vitamin content documented. • **Other phenolics**: Gallic acid, protocatechuic acid, and catechin in minor concentrations (<0.5%). • **Bioavailability notes**: TSG has moderate oral bioavailability in animal models (~20–30%), partially metabolized by gut microbiota into the aglycone form (resveratrol analogue). Emodin has poor oral bioavailability (~7–10% in rats) due to extensive first-pass glucuronidation and sulfation. Processing ('Pao Zhi') is traditionally required to reduce hepatotoxic free anthraquinone levels; raw (unprocessed) root carries higher risk of liver injury. Tannin content may chelate dietary minerals and reduce their absorption if taken with meals.

Preparation & Dosage

The research does not provide specific clinically studied dosage ranges for different forms of Fo-Ti or standardization protocols used in human studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Milk thistle, NAC (N-acetylcysteine), Alpha-lipoic acid, Green tea extract, Resveratrol

Safety & Interactions

Fo-ti, particularly processed forms, may cause hepatotoxicity in susceptible individuals, with several case reports of liver injury. Raw fo-ti contains higher levels of anthraquinones that can cause gastrointestinal upset and diarrhea. It may interact with medications metabolized by cytochrome P450 enzymes and could potentiate anticoagulant effects. Pregnant and breastfeeding women should avoid fo-ti due to insufficient safety data and potential hormonal effects.